Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans. 2008

Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. rimattiello@hotmail.com

OBJECTIVE To assess functional capacity during exercise in children and adolescents with post-infectious bronchiolitis obliterans (PIBO). METHODS 20 children with PIBO, aged 8-16 years old, and in follow-up at an outpatient clinic carried out cardiopulmonary exercise testing (CPET), a 6-minute walk test (6MWT) and pulmonary function tests (PFT), according to American Thoracic Society (ATS), European Respiratory Society (ERS) and American College of Chest Physicians (ACCP) guidelines. Results were expressed as percentages of predicted reference values: Armstrong's for CPET, Geiger's for 6MWT, Knudson's for spirometry, and Zapletal's for plethysmography. RESULTS Mean age (+/- SD) was 11.4+/-2.2 years; 70% were boys; mean weight: 36.8+/-12.3 kg; mean height: 143.8+/-15.2 cm. When compared to reference values, PFT detected lower airflows (spirometry) and higher volumes (plethysmography). Eleven patients had reduced peak VO2 values in CPET (< 84% predicted). The mean distance walked (6MWT) was 77.0+/-15.7% of predicted (512+/-102 m). Peak VO2 was not correlated with 6MWT, but it was correlated with FVC (L) (r = 0.90/p = 0.00), with FEV1 (L) (r = 0.86/p = 0.00) and with RV/TLC, both in absolute values (r = -0.71/p = 0.02) and as percentages of predicted values (r = -0.63/p = 0.00). CONCLUSIONS The majority of these post-infectious bronchiolitis obliterans patients exhibited reduced functional capacity, exhibited during both CPET and the 6MWT. Due to its greater feasibility, 6MWT could be an alternative where CPET is not available.

UI MeSH Term Description Entries
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D001989 Bronchiolitis Obliterans Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA. Bronchiolitis, Exudative,Bronchiolitis, Proliferative,Constrictive Bronchiolitis,Exudative Bronchiolitis,Proliferative Bronchiolitis,Bronchiolitides, Constrictive,Bronchiolitides, Exudative,Bronchiolitides, Proliferative,Bronchiolitis, Constrictive,Constrictive Bronchiolitides,Exudative Bronchiolitides,Proliferative Bronchiolitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory

Related Publications

Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
January 2019, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
January 2008, Jornal de pediatria,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
June 2022, Paediatric respiratory reviews,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
January 2011, Jornal de pediatria,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
February 2013, Revue des maladies respiratoires,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
February 2019, Pediatric pulmonology,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
January 2004, Pediatric pulmonology. Supplement,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
June 2006, Thorax,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
September 2014, Pediatric pulmonology,
Rita Mattiello, and Edgar E Sarria, and Ricardo Stein, and Gilberto Bueno Fischer, and Helena Teresinha Mocelin, and Sergio Saldanha Menna Barreto, and João Antônio Bonfadini Lima, and Diego Brandenburg
January 2011, Allergologia et immunopathologia,
Copied contents to your clipboard!